Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with ear mites (Otodectes cynotis).
Blazejak K, Viljoen A, Zwiegers R, Klopper R, Ringeisen H, Petry G, Young DR, Shane D, Spruill J, Tessman RK, Settje T, Knoppe TN, Mencke N. Blazejak K, et al. Curr Res Parasitol Vector Borne Dis. 2023 Jul 3;4:100131. doi: 10.1016/j.crpvbd.2023.100131. eCollection 2023. Curr Res Parasitol Vector Borne Dis. 2023. PMID: 37554314 Free PMC article.
Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
Heuer L, Petry G, Pollmeier M, Schaper R, Deuster K, Schmidt H, Blazejak K, Strube C, Di Cesare A, Traversa D, Schnyder M, McKay-Demeler J, von Samson-Himmelstjerna G, Mangold-Gehring S, Böhm C. Heuer L, et al. Among authors: blazejak k. Parasit Vectors. 2020 Feb 12;13(1):65. doi: 10.1186/s13071-020-3937-2. Parasit Vectors. 2020. PMID: 32051008 Free PMC article.
Multicenter randomized, and blinded European field study evaluating the efficacy and safety of Felpreva®, a novel spot-on formulation containing emodepside, praziquantel and tigolaner, in treating cats naturally infested with fleas and/or ticks.
Cvejić D, Hellmann K, Petry G, Ringeisen H, Hamburg H, Farkas R, Blazejak K, Mencke N. Cvejić D, et al. Among authors: blazejak k. Curr Res Parasitol Vector Borne Dis. 2022 Aug 10;2:100099. doi: 10.1016/j.crpvbd.2022.100099. eCollection 2022. Curr Res Parasitol Vector Borne Dis. 2022. PMID: 35991085 Free PMC article.
Efficacy of two topical combinations containing emodepside plus praziquantel, and emodepside plus praziquantel plus tigolaner, for the treatment of troglostrongylosis in experimentally infected cats.
Traversa D, Morelli S, Di Cesare A, Strube C, Raue K, Bisterfeld K, Boehm C, Pollmeier M, Ringeisen H, Blazejak K, Mencke N. Traversa D, et al. Among authors: blazejak k. Curr Res Parasitol Vector Borne Dis. 2022 Aug 10;2:100097. doi: 10.1016/j.crpvbd.2022.100097. eCollection 2022. Curr Res Parasitol Vector Borne Dis. 2022. PMID: 35991087 Free PMC article.
Efficacy and safety of Felpreva®, a spot-on formulation for cats containing emodepside, praziquantel and tigolaner against experimental infestation with the Australian paralysis tick Ixodes holocyclus.
Roeber F, Jackson C, Chambers M, Smith V, Hume J, Blazejak K, Mencke N. Roeber F, et al. Among authors: blazejak k. Curr Res Parasitol Vector Borne Dis. 2023 May 30;4:100123. doi: 10.1016/j.crpvbd.2023.100123. eCollection 2023. Curr Res Parasitol Vector Borne Dis. 2023. PMID: 37416339 Free PMC article.
Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis.
Mencke N, Blazejak K, Petry G, Hamburg H, Ringeisen H, Knoppe TN, Viljoen A, Smith A, Spruill J. Mencke N, et al. Among authors: blazejak k. Curr Res Parasitol Vector Borne Dis. 2023 May 30;3:100122. doi: 10.1016/j.crpvbd.2023.100122. eCollection 2023. Curr Res Parasitol Vector Borne Dis. 2023. PMID: 37441539 Free PMC article.
Plasma pharmacokinetics of tigolaner, emodepside, and praziquantel following topical administration of a combination product (Felpreva®) and of intravenous administration of the individual active ingredients in cats.
Mencke N, Bäumer W, Fraatz K, Krebber R, Schneider M, Blazejak K. Mencke N, et al. Among authors: blazejak k. Curr Res Parasitol Vector Borne Dis. 2023 Jun 22;4:100126. doi: 10.1016/j.crpvbd.2023.100126. eCollection 2023. Curr Res Parasitol Vector Borne Dis. 2023. PMID: 37456557 Free PMC article.
Field efficacy and safety of Felpreva® (tigolaner, emodepside and praziquantel) spot-on for the treatment of natural ear mite infestations (Otodectes cynotis) and notoedric mange (Notoedres cati) in cats.
Blazejak K, Cvejić D, Hellmann K, Ringeisen H, Hamburg H, Petry G, Knoppe TN, Mencke N. Blazejak K, et al. Curr Res Parasitol Vector Borne Dis. 2023 Sep 23;4:100146. doi: 10.1016/j.crpvbd.2023.100146. eCollection 2023. Curr Res Parasitol Vector Borne Dis. 2023. PMID: 37954512 Free PMC article.
13 results